209 Cutaneous Nevi and Risk of Melanoma Deaths in Women and Men: A Prospective Study

Wenqing Li,Eunyoung Cho,Martin A. Weinstock,Abrar A. Qureshi
DOI: https://doi.org/10.1016/j.jid.2017.02.224
IF: 7.59
2017-01-01
Journal of Investigative Dermatology
Abstract:Increased number of common acquired melanocytic nevi (moles) has been associated with elevated risk of melanoma but whether it may predict melanoma deaths was unclear. We prospectively examined the association between number of nevi and risk of melanoma deaths based on 77,316 women from the Nurses' Health Study (NHS) and 32,454 men from the Health Professionals Follow-up Study (HPFS). Diagnosis of melanoma was pathologically confirmed. Deaths were confirmed by next of kin or the National Death Index. Information on number of moles with ≥3 mm diameter on the upper extremity was collected in 1986. We used Cox regression models to evaluate the associations in the overall cohorts as well as only among melanoma cases. During follow-up (1986-2012), 2,450 melanoma cases were documented (1,545 in NHS and 905 in HPFS), out of which we identified 192 incident deaths from melanoma (87 in NHS and 105 in HPFS). Increased number of nevi was associated with melanoma deaths; the multivariate-adjusted hazard ratio (HR) for ≥3 nevi compared with no nevi on the upper extremity was 2.55 [95% confidence interval (CI): 1.52-4.28] for women and 3.97 (95% CI: 2.54-6.22) for men. A secondary analysis further found that increased number of nevi was associated with both lethal melanoma (melanoma cases that died of melanoma) and non-lethal melanoma. Among melanoma cases, increased number of nevi was independently associated with risk of melanoma deaths in men, with a HR of 1.89 (95% CI: 1.17-3.05) for ≥3 nevi. The association persisted after adjusting for Breslow thickness of melanoma. However, number of nevi was not significantly associated with risk of melanoma deaths among women melanoma cases (HR=1.03, 95% CI: 0.61-1.76 for ≥3 nevi). In conclusion, increased number of nevi was significantly associated with risk of melanoma deaths in our cohorts of women and men. A high number of cutaneous nevi may independently predict the risk of melanoma deaths among men with melanoma.
What problem does this paper attempt to address?